Jeremy P Springhorn

This inventor holds 8 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignees: Alexion Pharmaceuticals, Inc., Bioprocessors Corp.. Active years: 1999-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeremy P Springhorn. Retrieved from https://idiyas.com/inventor/jeremy-p-springhorn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 1)

% Patents Active = 75.0

CIPO Patents = 2 (Patent Applications = 4)

EPO Patents = 2 (Patent Applications = 9)

Average Co-Inventor Count = 4.5

ph-index = 5

Forward Citations = 284(Granted Patents)

Location History:

Cheshire, CT (US) (1999 - 2002)
Guilford, CT (US) (2002 - 2016)

Company Filing History:

7 out of 199

Alexion Pharmaceuticals, Inc.

Years Active: 1999-2016

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9493551 - Antibodies containing therapeutic TPO/EPO mimetic peptides (2016-11-15),

2. 9000133 - Antibodies to OX-2/CD200 and uses thereof (2015-04-07),

3. 8709415 - Antibodies to OX-2/CD200 and uses thereof (2014-04-29),

4. 8075884 - Antibodies to OX-2/CD200 and uses thereof (2011-12-13),

5. 6905657 - Methods and devices for storing and dispensing liquids (2005-06-14),

6. 6355245 - C5-specific antibodies for the treatment of inflammatory diseases (2002-03-12),

7. 6338820 - Apparatus for performing assays at reaction sites (2002-01-15),

8. 5871997 - Methods and compositions for protecting retroviral vector particles and (1999-02-16),

Title: The Innovative Contributions of Jeremy P. Springhorn

Introduction

Jeremy P. Springhorn is a notable inventor based in Guilford, CT (US), recognized for his significant contributions to the field of therapeutic antibodies. With a total of 8 patents to his name, Springhorn has made strides in developing innovative solutions for medical applications.

Latest Patents

Among his latest patents, one includes "Antibodies containing therapeutic TPO/EPO mimetic peptides." This patent features therapeutic antibodies, specifically TPO mimetic antibodies, and their fragments, which are useful in various diagnostic and therapeutic applications, including methods for increasing platelet levels in a subject. Another significant patent is "Antibodies to OX-2/CD200 and uses thereof," which provides methods and compositions for modulating and depleting CD200 positive cells.

Career Highlights

Springhorn has worked with prominent companies in the biotechnology sector, including Alexion Pharmaceuticals, Inc. and Bioprocessors Corporation. His work in these organizations has contributed to advancements in therapeutic solutions and innovative research.

Collaborations

Throughout his career, Springhorn has collaborated with esteemed colleagues such as Scott A. Rollins and Stephen P. Squinto, further enhancing the impact of his work in the field.

Conclusion

Jeremy P. Springhorn's innovative contributions to therapeutic antibodies and his collaborations with leading professionals in the industry underscore his importance as an inventor. His work continues to influence advancements in medical therapies and diagnostics.

Profile summary based on public USPTO records.